TSLP and cancer: Chan et al. employed cell viability and cancer organoid assays in order to investigate the effect of overexpression of short-form thymic stromal lymphopoietin (sfTSLP), an epithelial cell derived cytokine, on tumor growth in vitro, and showed significantly higher numbers of viable cells of sfTSLP-expressing ovarian A2780 and IGROV-1 cancer cells, thus confirming its upregulation in OC [42].